1,563 followers
@NICEComms @ERSpublications @LondonAsthma Tezepelumab is a mAb targeting the alarmin TSLP, which is released by epithelial cells in response to pro-inflammatory stimuli. It sits higher up the inflammatory cascade than IL-5, IL-4 & IL-13 so blocking it